Equity Overview
Price & Market Data
Price: $0.81
Daily Change: +$0.0469 / 5.79%
Daily Range: $0.77 - $0.85
Market Cap: $22,033,318
Daily Volume: 124,444
Performance Metrics
1 Week: -7.57%
1 Month: -24.35%
3 Months: -49.09%
6 Months: -93.68%
1 Year: -92.39%
YTD: -92.79%
Company Details
Employees: 3
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Liminatus Pharma, Inc. operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies. It is developing CD47, a high affinity humanized anti CD47 antibody that has the potential to translate into clinic for CD47 SIRPa blocking and restoring the anti-tumor function of innate immune cells without inducing hemagglutination or hemolysis. The company was founded in 2018 is based in LA Palma, California.